Key Findings:  Human bladder cancer cell lines (RT4, RT112) were treated with CB agonists to assess proliferation, apoptosis, and motility. The CB2 agonist JWH-015 induced anti-proliferative activity and inhibited bladder cancer cell growth.
Type of Study:  Laboratory Study
Study Result:  Positive
Study Location(s):  Italy, Sweden, United States
Year of Pub:  2017
Cannabinoids Studied:  JWH-x Synthetic Cannabinoids
Phytocannabinoid Source:  Not Applicable
Receptors Studied:  CB2